Neoplasms
|
0.100 |
PosttranslationalModification
|
group |
BEFREE |
Cr(VI) is genotoxic, forming protein-Cr-DNA adducts and silencing tumor suppressor genes, but its mechanism of action at the molecular level is poorly understood.
|
29561703 |
2018 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Nude mice injected with BEAS-2B cells chronically exposed to Cr(VI) in the presence of quercetin showed reduced tumor incidence compared to Cr(VI) alone treated group.
|
28881718 |
2017 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression.
|
26843424 |
2016 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Here, we report that the Smad-interacting protein-1 (SIP1) is transcriptionally activated and functions critically in the GADD45G-induced tumor cell senescence.
|
26378039 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Nude mice injected with BEAS-2B cells chronically exposed to Cr(VI) in the presence of luteolin showed reduced tumor incidence compared to Cr(VI) alone treated group.
|
25448439 |
2014 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
These data indicated that Gadd45G may be a functional tumor suppressor and its inactivation through proximal promoter methylation may play an important role in ESCC carcinogenesis and reactivation of Gadd45G gene may has therapeutic potential and may be used as a prognostic marker for ESCC patients.
|
23793925 |
2013 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
These results suggest that GADD45A and GADD45G gene may act as functional tumor suppressor but being frequently inactivated epigenetically in patients with GCA.
|
23616123 |
2013 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Another deletion removes a forebrain subventricular zone enhancer near the tumour suppressor gene growth arrest and DNA-damage-inducible, gamma (GADD45G), a loss correlated with expansion of specific brain regions in humans.
|
21390129 |
2011 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Chronic Cr(VI) exposure resulted in transformation of Beas-2B cells, increasing cell proliferation, anchorage independent growth in soft agar, and forming aggressive tumors in nude mice.
|
21742780 |
2011 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Given that GADD45γ is becoming increasingly recognized for its tumor suppressor function, the results presented here suggest the novel possibility that (--)-xanthatin may have therapeutic value as a selective inducer of GADD45γ in human cancer cells, in particular in FTI-resistant aggressive breast cancers.
|
21568272 |
2011 |
Neoplasms
|
0.100 |
PosttranslationalModification
|
group |
BEFREE |
And this is the first study to evaluate the prevalence of GADD45G methylation based on large amount of tumor samples, showing that epigenetic regulation of GADD45G was associated with carcinogenesis.
|
20111973 |
2010 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
These results show that GADD45G can act as a functional new-age tumor suppressor but being frequently inactivated epigenetically in multiple tumors.
|
16166418 |
2005 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Silencing of GADD45gamma, a negative regulator of cell growth, is most likely responsible for conferring a selective growth advantage during tumour evolution and outgrowth.
|
14647444 |
2004 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Furthermore, the adenovirus-mediated delivery of Gadd45gamma gene in anaplastic thyroid cancer resulted in the inhibition of tumor growth in vivo.
|
12915687 |
2003 |